Prevalence of Select New Symptoms and Conditions Among Persons Aged Younger Than 20 Years and 20 Years or Older at 31 to 150 Days After Testing Positive or Negative for SARS-CoV-2
- PMID: 35119459
- PMCID: PMC8817203
- DOI: 10.1001/jamanetworkopen.2021.47053
Prevalence of Select New Symptoms and Conditions Among Persons Aged Younger Than 20 Years and 20 Years or Older at 31 to 150 Days After Testing Positive or Negative for SARS-CoV-2
Abstract
Importance: New symptoms and conditions can develop following SARS-CoV-2 infection. Whether they occur more frequently among persons with SARS-CoV-2 infection compared with those without is unclear.
Objective: To compare the prevalence of new diagnoses of select symptoms and conditions between 31 and 150 days after testing among persons who tested positive vs negative for SARS-CoV-2.
Design, setting, and participants: This cohort study analyzed aggregated electronic health record data from 40 health care systems, including 338 024 persons younger than 20 years and 1 790 886 persons aged 20 years or older who were tested for SARS-CoV-2 during March to December 2020 and who had medical encounters between 31 and 150 days after testing.
Main outcomes and measures: International Statistical Classification of Diseases, Tenth Revision, Clinical Modification codes were used to capture new symptoms and conditions that were recorded 31 to 150 days after a SARS-CoV-2 test but absent in the 18 months to 7 days prior to testing. The prevalence of new symptoms and conditions was compared between persons with positive and negative SARS-CoV-2 tests stratified by age (20 years or older and young than 20 years) and care setting (nonhospitalized, hospitalized, or hospitalized and ventilated).
Results: A total of 168 701 persons aged 20 years or older and 26 665 younger than 20 years tested positive for SARS-CoV-2, and 1 622 185 persons aged 20 years or older and 311 359 younger than 20 years tested negative. Shortness of breath was more common among persons with a positive vs negative test result among hospitalized patients (≥20 years: prevalence ratio [PR], 1.89 [99% CI, 1.79-2.01]; <20 years: PR, 1.72 [99% CI, 1.17-2.51]). Shortness of breath was also more common among nonhospitalized patients aged 20 years or older with a positive vs negative test result (PR, 1.09 [99% CI, 1.05-1.13]). Among hospitalized persons aged 20 years or older, the prevalence of new fatigue (PR, 1.35 [99% CI, 1.27-1.44]) and type 2 diabetes (PR, 2.03 [99% CI, 1.87-2.19]) was higher among those with a positive vs a negative test result. Among hospitalized persons younger than 20 years, the prevalence of type 2 diabetes (PR, 2.14 [99% CI, 1.13-4.06]) was higher among those with a positive vs a negative test result; however, the prevalence difference was less than 1%.
Conclusions and relevance: In this cohort study, among persons hospitalized after a positive SARS-CoV-2 test result, diagnoses of certain symptoms and conditions were higher than among those with a negative test result. Health care professionals should be aware of symptoms and conditions that may develop after SARS-CoV-2 infection, particularly among those hospitalized after diagnosis.
Conflict of interest statement
Figures
Similar articles
-
Post-COVID-19 Conditions Among Children 90 Days After SARS-CoV-2 Infection.JAMA Netw Open. 2022 Jul 1;5(7):e2223253. doi: 10.1001/jamanetworkopen.2022.23253. JAMA Netw Open. 2022. PMID: 35867061 Free PMC article.
-
Association between SARS-CoV-2 infection and select symptoms and conditions 31 to 150 days after testing among children and adults.BMC Infect Dis. 2024 Feb 10;24(1):181. doi: 10.1186/s12879-024-09076-8. BMC Infect Dis. 2024. PMID: 38341566 Free PMC article.
-
Association of Age With Likelihood of Developing Symptoms and Critical Disease Among Close Contacts Exposed to Patients With Confirmed SARS-CoV-2 Infection in Italy.JAMA Netw Open. 2021 Mar 1;4(3):e211085. doi: 10.1001/jamanetworkopen.2021.1085. JAMA Netw Open. 2021. PMID: 33688964 Free PMC article.
-
Prevalence of the Most Frequent Neuropsychiatric Diagnoses in Hospitalized SARS-CoV-2 Patients Evaluated by Liaison Psychiatry: Cross-Sectional Study.Acta Med Port. 2022 Jun 1;35(6):425-432. doi: 10.20344/amp.16410. Epub 2022 Feb 16. Acta Med Port. 2022. PMID: 35171094 Review.
-
COVID-19 in patients with Down syndrome: A systematic review.Immun Inflamm Dis. 2024 Mar;12(3):e1219. doi: 10.1002/iid3.1219. Immun Inflamm Dis. 2024. PMID: 38501534 Free PMC article. Review.
Cited by
-
Association between SARS-CoV-2 infection before the age of two and child development.Pediatr Res. 2024 Oct 12. doi: 10.1038/s41390-024-03614-5. Online ahead of print. Pediatr Res. 2024. PMID: 39394427
-
Risk of New-Onset Diabetes Before and During the COVID-19 Pandemic: A Real-World Cohort Study.J Gen Intern Med. 2024 Sep 20. doi: 10.1007/s11606-024-09035-8. Online ahead of print. J Gen Intern Med. 2024. PMID: 39302562
-
Body mass index changes and their association with SARS-CoV-2 infection: a real-world analysis.Int J Obes (Lond). 2024 Sep 14. doi: 10.1038/s41366-024-01628-x. Online ahead of print. Int J Obes (Lond). 2024. PMID: 39277656
-
Characterizing Long COVID in Children and Adolescents.JAMA. 2024 Aug 21:e2412747. doi: 10.1001/jama.2024.12747. Online ahead of print. JAMA. 2024. PMID: 39196964
-
Public Health Surveillance in Electronic Health Records: Lessons From PCORnet.Prev Chronic Dis. 2024 Jul 11;21:E51. doi: 10.5888/pcd21.230417. Prev Chronic Dis. 2024. PMID: 38991533 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous